2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This scientific session will examine emerging concepts in spinal cord (SC)-focused MS and demyelinating disease, highlighting how advances in pathology, imaging, and mechanistic understanding are reshaping traditional models of central nervous system demyelination. Particular attention will be given to the SC as a critical …
Continue reading “Spinal Cord Variants: Special Considerations in MS Diagnosis and Treatment”
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE Digital health tools are rapidly reshaping how multiple sclerosis (MS) care is delivered. Telehealth visits, remote monitoring platforms, electronic patient-reported outcomes, and mobile apps now play a central role in how MS nurses, advanced practice providers, and PAs connect with patients. While these tools …
2026 Charlotte, NC sessions AAPA, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE Wearables have evolved from research-based instruments into commercially-available sensors that continuously capture real-world function and lived experiences. In multiple sclerosis (MS), accelerometry and ecological momentary assessments (EMAs) captured by wearables provide reliable indicators of health, activity, and sleep/wake patterns, holding strong …
Continue reading “Integrating Wearables into MS Clinical Care: From Research to Routine Practice”
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Spinal cord disease is important in most people with MS , but is less emphasized in patient care, basic, clinical research, and therapeutic trials. Clinically relevant spinal cord disease in MS is crucial to recognize. How and when to image the spinal cord …
Continue reading “Spinal Cord in MS: Key Clinical and Imaging Considerations”
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Invisible symptoms of multiple sclerosis (MS), including fatigue, cognitive/mood impairment, and sensory disturbances, are major contributors to functional decline and diminished quality of life (QoL), yet remain understudied, underrecognized, and undertreated in people with MS. In this session, we …
2026 Charlotte, NC sessions AAPA, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE Cognitive impairment is a well-documented issue in multiple sclerosis (MS), with annual screenings recommended by several international MS organizations. However, a number of survey studies in the United States and Europe have indicated that cognitive screenings are not routinely done, which …
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE OCT (optical coherence tomography) has significantly advanced the clinical practice of neuro-ophthalmology, including the care of patients with demyelinating disease. OCT is a non-invasive, reliable, financially accessible technique for visualizing structures in the eye including the retinal nerve fiber layer (RNFL) and ganglion cell-inner …
Continue reading “OCT Across the Spectrum of Demyelinating Disease”
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE These Sessions offer a multidisciplinary approach to the diagnosis and management of multiple sclerosis. A comprehensive overview of MS will be presented to include epidemiology, immunology, pathophysiology, natural history, and clinical course. Presentations will include unraveling the complexity of making diagnosis and use …
2026 Charlotte, NC sessions AAPA, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE The heterogeneous presentation and unpredictable progression of people with multiple sclerosis (pwMS) result in a unique challenge for clinicians. Compared to other neurological diagnoses commonly seen by rehabilitation clinicians, limited evidence is available to guide intervention. A large share of the …